Growth Drivers
Challenges
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the North America is predicted to grow at the highest CAGR over the forecast period owing to significant factors supporting the growth of this market in the region which is due to the prominent growth of cases in xerostomia as well as various other diseases associated with dry mouths such as rheumatoid arthritis, HIV, and Sjogren's syndrome. Sjogren Syndrome Foundation frequently carries out awareness camps regarding the therapies and remedies for the people with xerostomia across U.S. and Canada. Furthermore, expanding medical and healthcare infrastructure, ease of availability of treatments, and beneficial compensation scenario are some of the important factors which are helping the market to grow in the North American region. Asia Pacific’s market is expected to gain traction and is expected to grow at a faster rate during the forecast period. Increased spending towards healthcare, growing understanding and awareness about chronic diseases are anticipated to strengthen the xerostomia therapeutics market in the Asia Pacific.
The global xerostomia therapeutics market is further classified on the basis of region as follows:
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
3.9% |
Base Year Market Size (2024) |
USD 2.14 billion |
Forecast Year Market Size (2037) |
USD 3.52 billion |
Regional Scope |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?